Endoscopic bipolar radiofrequency ablation for malignant biliary obstructionStatus:Awaiting development | In consultationProgramme:Interventional procedures guidanceConsultation end date: 28 June 2024Expected publication date: 14 November 2024
Lutetium oxodotreotide with octreotide for newly diagnosed unresectable or metastatic gastroenteropancreatic neuroendocrine tumours [ID6315]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Pembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal) (TA966)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 April 2024
Percutaneous intraductal radiofrequency ablation for malignant biliary obstructionStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer TSID 12040Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC